Effects of Liposomal Bupivacaine for Acute Pain in Hip and Femur Fractures: a Randomized, Active Comparator-controlled, Blinded Trial
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 20 Sep 2017
At a glance
- Drugs Bupivacaine (Primary) ; Ropivacaine
- Indications Pain
- Focus Therapeutic Use
- 14 Sep 2017 Planned End Date changed from 1 Aug 2017 to 1 Aug 2018.
- 14 Sep 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Aug 2018.
- 14 Sep 2017 Status changed from not yet recruiting to active, no longer recruiting.